Irish medtech company Kinesis Health Technologies is to participate in a new NHS Innovation test beds initiative to improve patient care throughout the UK.
The UCD spin-out is the latest in a list of companies to have worked with the NHS, including Verily (formerly Google Life Sciences), IBM and Philips.
UNder the project frontline healthcare workers in seven ‘test bed’ areas will pioneer and evaluate the use of novel combinations of interconnected devices and wearable sensors, to provide data that will inform the development of ways to monitor patients and their conditions themselves at home.
Successful innovations will then be available for other parts of the UK to adopt and adapt to the particular needs of their local populations.
Kinesis will participate in two of the seven test beds, deploying its QTUG mobility and falls risk assessment technology at the Care City Health and Care Test Bed in London and the Perfect Patient Pathway Test Bed in Sheffield.
Kinesis QTUG aims to reduce incidences of falls in older adults and combines advanced technology, including body-worn sensors, with the clinical standard Timed Up and Go procedure into a solution that can be used to assess falls risk and mobility impairment in older adults.
Seamus Small, chief executive officer, Kinesis, said: “To collaborate with NHS and other leading innovators is an excellent opportunity to evaluate and advance the adoption of innovative solutions and practices, including QTUG, our evidence-based mobility and falls risk assessment technology, into the NHS.”
TechCentral Reporters
Subscribers 0
Fans 0
Followers 0
Followers